Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients
NCT06291194
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
396
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndromes
Interventions
DRUG:
AJU-S56 5%
DRUG:
Placebo Group(Vehicle)
Sponsor
AJU Pharm Co., Ltd.
Collaborators
[object Object]